Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

Contributed by: PR Newswire

Tags

CAMURUS-AB-study

More Like This

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

Business Wire logo

Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites

Luoxin Pharmaceutical's LX-039 (Innovative Anti-Tumor Drug): Phase I Clinical Study Data Presented at ESMO 2023

Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

PR Newswire associated0

ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability